An automated immunoassay for early specificity profiling of antibodies

References

• Zhou H, Zhang YL, Lu G, Ji H, Rodi CP. Recombinant antibody libraries and selection technologies. N Biotechnol 2011; 28:448 - 52; http://dx.doi.org/10.1016/j.nbt.2011.03.013; PMID: 21477669
   PubMed Web of Science ®Google Scholar
• Reichert JM. Which are the antibodies to watch in 2012?. MAbs 2012; 4:1 - 3; http://dx.doi.org/10.4161/mabs.4.1.18719; PMID: 22327425
   PubMed Web of Science ®Google Scholar
• Reichert JM. Marketed therapeutic antibodies compendium. MAbs 2012; 4:413 - 5; http://dx.doi.org/10.4161/mabs.19931; PMID: 22531442
   PubMed Web of Science ®Google Scholar
• Notkins AL. Polyreactivity of antibody molecules. Trends Immunol 2004; 25:174 - 9; http://dx.doi.org/10.1016/j.it.2004.02.004; PMID: 15039043
   PubMed Web of Science ®Google Scholar
• Mohan S, Kourentzi K, Schick KA, Uehara C, Lipschultz CA, Acchione M, et al. Association energetics of cross-reactive and specific antibodies. Biochemistry 2009; 48:1390 - 8; http://dx.doi.org/10.1021/bi801901d; PMID: 19166328
   PubMed Web of Science ®Google Scholar
• Hötzel I, Theil FP, Bernstein LJ, Prabhu S, Deng R, Quintana L, et al. A strategy for risk mitigation of antibodies with fast clearance. MAbs 2012; 4:753 - 60; http://dx.doi.org/10.4161/mabs.22189
   PubMed Web of Science ®Google Scholar
• Zhu H, Bilgin M, Bangham R, Hall D, Casamayor A, Bertone P, et al. Global analysis of protein activities using proteome chips. Science 2001; 293:2101 - 5; http://dx.doi.org/10.1126/science.1062191; PMID: 11474067
   PubMed Web of Science ®Google Scholar
• Diehnelt CW, Shah M, Gupta N, Belcher PE, Greving MP, Stafford P, et al. Discovery of high-affinity protein binding ligands--backwards. PLoS One 2010; 5:e10728; http://dx.doi.org/10.1371/journal.pone.0010728; PMID: 20502719
   PubMedGoogle Scholar
• Lueking A, Possling A, Huber O, Beveridge A, Horn M, Eickhoff H, et al. A nonredundant human protein chip for antibody screening and serum profiling. Mol Cell Proteomics 2003; 2:1342 - 9; http://dx.doi.org/10.1074/mcp.T300001-MCP200; PMID: 14517340
   PubMed Web of Science ®Google Scholar
• Feyen O, Lueking A, Kowald A, Stephan C, Meyer HE, Göbel U, et al. Off-target activity of TNF-alpha inhibitors characterized by protein biochips. Anal Bioanal Chem 2008; 391:1713 - 20; http://dx.doi.org/10.1007/s00216-008-1938-7; PMID: 18344017
   PubMed Web of Science ®Google Scholar
• Lueking A, Beator J, Patz E, Müllner S, Mehes G, Amersdorfer P. Determination and validation of off-target activities of anti-CD44 variant 6 antibodies using protein biochips and tissue microarrays. [Pi-Pv.] Biotechniques 2008; 45; http://dx.doi.org/10.2144/000112898; PMID: 18855764
   PubMedGoogle Scholar
• Ponsel D, Neugebauer J, Ladetzki-Baehs K, Tissot K. High affinity, developability and functional size: the holy grail of combinatorial antibody library generation. Molecules 2011; 16:3675 - 700; http://dx.doi.org/10.3390/molecules16053675; PMID: 21540796
   PubMed Web of Science ®Google Scholar
• Prassler J, Thiel S, Pracht C, Polzer A, Peters S, Bauer M, et al. HuCAL PLATINUM, a synthetic Fab library optimized for sequence diversity and superior performance in mammalian expression systems. J Mol Biol 2011; 413:261 - 78; http://dx.doi.org/10.1016/j.jmb.2011.08.012; PMID: 21856311
   PubMed Web of Science ®Google Scholar
• Steidl S, Ratsch O, Brocks B, Dürr M, Thomassen-Wolf E. In vitro affinity maturation of human GM-CSF antibodies by targeted CDR-diversification. Mol Immunol 2008; 46:135 - 44; http://dx.doi.org/10.1016/j.molimm.2008.07.013; PMID: 18722015
   PubMed Web of Science ®Google Scholar
• Ewert S, Honegger A, Plückthun A. Structure-based improvement of the biophysical properties of immunoglobulin VH domains with a generalizable approach. Biochemistry 2003; 42:1517 - 28; http://dx.doi.org/10.1021/bi026448p; PMID: 12578364
   PubMed Web of Science ®Google Scholar
• Brocks B, Garin-Chesa P, Behrle E, Park JE, Rettig WJ, Pfizenmaier K, et al. Species-crossreactive scFv against the tumor stroma marker “fibroblast activation protein” selected by phage display from an immunized FAP-/- knock-out mouse. Mol Med 2001; 7:461 - 9; PMID: 11683371
   PubMed Web of Science ®Google Scholar
• Abdiche YN, Malashock DS, Pons J. Probing the binding mechanism and affinity of tanezumab, a recombinant humanized anti-NGF monoclonal antibody, using a repertoire of biosensors. Protein Sci 2008; 17:1326 - 35; http://dx.doi.org/10.1110/ps.035402.108; PMID: 18505735
   PubMed Web of Science ®Google Scholar
• Abdiche YN, Lindquist KC, Stone DM, Rajpal A, Pons J. Label-free epitope binning assays of monoclonal antibodies enable the identification of antigen heterogeneity. J Immunol Methods 2012; 382:101 - 16; http://dx.doi.org/10.1016/j.jim.2012.05.010; PMID: 22609372
   PubMed Web of Science ®Google Scholar
• Lauer TM, Agrawal NJ, Chennamsetty N, Egodage K, Helk B, Trout BL. Developability index: a rapid in silico tool for the screening of antibody aggregation propensity. J Pharm Sci 2012; 101:102 - 15; http://dx.doi.org/10.1002/jps.22758; PMID: 21935950
   PubMed Web of Science ®Google Scholar
• Spencer S, Bethea D, Raju TS, Giles-Komar J, Feng Y. Solubility evaluation of murine hybridoma antibodies. MAbs 2012; 4:319 - 25; http://dx.doi.org/10.4161/mabs.19869; PMID: 22531448
   PubMed Web of Science ®Google Scholar
• Rhyne PW, Wong OT, Zhang YJ, Weiner RS. Electrochemiluminescence in bioanalysis. Bioanalysis 2009; 1:919 - 35; http://dx.doi.org/10.4155/bio.09.80; PMID: 21083063
   PubMed Web of Science ®Google Scholar
• Lu Y, Wong WL, Meng YG. A high throughput electrochemiluminescent cell-binding assay for therapeutic anti-CD20 antibody selection. J Immunol Methods 2006; 314:74 - 9; http://dx.doi.org/10.1016/j.jim.2006.05.011; PMID: 16814318
   PubMed Web of Science ®Google Scholar
• Scholz M, Lüking A. A protein-stabilizing technology for enhanced antibody stability and antibody-binding profiles in a microchip array. Biotechnol J 2012; 7:1002 - 7; http://dx.doi.org/10.1002/biot.201100494; PMID: 22422601
   PubMed Web of Science ®Google Scholar
• Berinstein NL, Grillo-López AJ, White CA, Bence-Bruckler I, Maloney D, Czuczman M, et al. Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin’s lymphoma. Ann Oncol 1998; 9:995 - 1001; http://dx.doi.org/10.1023/A:1008416911099; PMID: 9818074
   PubMed Web of Science ®Google Scholar
• Loyet KM, Deng R, Liang WC, Wu Y, Lowman HB, DeForge LE. Technology comparisons for anti-therapeutic antibody and neutralizing antibody assays in the context of an anti-TNF pharmacokinetic study. J Immunol Methods 2009; 345:17 - 28; http://dx.doi.org/10.1016/j.jim.2009.03.012; PMID: 19345224
   PubMed Web of Science ®Google Scholar
• Dabitao D, Margolick JB, Lopez J, Bream JH. Multiplex measurement of proinflammatory cytokines in human serum: comparison of the Meso Scale Discovery electrochemiluminescence assay and the Cytometric Bead Array. J Immunol Methods 2011; 372:71 - 7; http://dx.doi.org/10.1016/j.jim.2011.06.033; PMID: 21781970
   PubMed Web of Science ®Google Scholar